☰

Anna Huber - Publications

Affiliations: 
University of Oxford, Oxford, United Kingdom 
Area:
dopamine; reinforcement learning; animal models; mental disorder; fast-scan cyclic voltammetry
Tree Info Grants Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Korn C, Akam T, Jensen KHR, Vagnoni C, Huber A, Tunbridge EM, Walton ME. Distinct roles for dopamine clearance mechanisms in regulating behavioral flexibility. Molecular Psychiatry. PMID 34193974 DOI: 10.1038/s41380-021-01194-y  0.388
2014 Barkus C, Line SJ, Huber A, Capitao L, Lima J, Jennings K, Lowry J, Sharp T, Bannerman DM, McHugh SB. Variation in serotonin transporter expression modulates fear-evoked hemodynamic responses and theta-frequency neuronal oscillations in the amygdala. Biological Psychiatry. 75: 901-8. PMID 24120093 DOI: 10.1016/J.Biopsych.2013.09.003  0.328
2013 Baudonnat M, Huber A, David V, Walton ME. Heads for learning, tails for memory: reward, reinforcement and a role of dopamine in determining behavioral relevance across multiple timescales. Frontiers in Neuroscience. 7: 175. PMID 24130514 DOI: 10.3389/Fnins.2013.00175  0.722
2012 Tunbridge EM, Huber A, Farrell SM, Stumpenhorst K, Harrison PJ, Walton ME. The role of catechol-O-methyltransferase in reward processing and addiction. Cns & Neurological Disorders Drug Targets. 11: 306-23. PMID 22483300 DOI: 10.2174/187152712800672409  0.689
2011 McCabe C, Huber A, Harmer CJ, Cowen PJ. The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers. Psychopharmacology. 217: 271-8. PMID 21494790 DOI: 10.1007/S00213-011-2278-4  0.601
1991 Shippenberg TS, Bals-Kubik R, Huber A, Herz A. Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists. Psychopharmacology. 103: 209-14. PMID 1827526 DOI: 10.1007/BF02244205  0.402
Show low-probability matches.